Related Experiment Video
Updated: Aug 17, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
Amyotrophic lateral sclerosis
1Neuromuscular Diseases Unit, Vancouver General Hospital, Canada.
Abstract:
The final cascade of amyotrophic lateral sclerosis (ALS) coincides with the onset of clinical neurological deficits and involves multifactorial interactive mechanisms. These terminal events include excitotoxicity, free radical accumulation and possibly immunological disturbances. They are probably predated by months or years by thus far unidentified triggers. Selective vulnerability of the corticomotneuronal system in ALS is likely due to degradation of several gene products essential to transmitter, receptor and nerve growth factor maintenance specific to this functional system. Therapeutic strategies involve neuroprotection, symptomatic and combination neuronal therapy targeted to the final cascade of ALS.
Related Concept Videos
Cross-bridge Cycle
Satellite Stem Cells and Muscular Dystrophy
Parkinson's Disease: Overview
Multiple Sclerosis l: Introduction
Myasthenia Gravis ll: Pathophysiology
Alterations in Muscle Tone lll

